Is EPOC a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

90 people get EPOC articles and Market Currents by email alert.

Get email alerts on EPOC »

HEADLINES:

Epocrates Helped Physicians Avoid 27 Million Drug Errors in 2012

GlobeNewswire (Jan 23, 2013)
Epocrates to Present at the 31st Annual J.P. Morgan Healthcare Conference

GlobeNewswire (Dec 17, 2012)
Photo Release -- Epocrates Launches Application for iPad and iPad mini

GlobeNewswire (Dec 6, 2012)
Epocrates CEO to Present at Two Healthcare Investor Conferences

GlobeNewswire (Nov 1, 2012)
Epocrates Announces Third Quarter 2012 Results

GlobeNewswire (Oct 30, 2012)
Epocrates Market Research Panel Aces Industry Report Card

GlobeNewswire (Oct 26, 2012)
Epocrates Updates Third Quarter Earnings Conference Call Time

GlobeNewswire (Oct 11, 2012)
Epocrates Announces Third Quarter Earnings Release Date and Conference Call

GlobeNewswire (Oct 9, 2012)
Epocrates Invests in Future Physicians

GlobeNewswire (Aug 17, 2012)
Epocrates Announces Second Quarter 2012 Results

GlobeNewswire (Aug 7, 2012)
Post-Hype Sleeper: Checking Out Epocrates' Oath To Customers, Investors
Daniel Shvartsman • Tue, Jul 31, 2012 • 1 Comment
Epocrates Announces Second Quarter Earnings Release Date and Conference Call

GlobeNewswire (Jul 10, 2012)
4 Companies Poised To Control The New Mobile App Economy
AppHead • Thu, May 24, 2012 • 11 Comments
Epocrates Reigns as Physicians' Top Mobile App According to New Manhattan Research Study

GlobeNewswire (May 22, 2012)
WebMD Health: Attractive Takeover Target With Strong Competitive Advantage
NYU Value Investor • Tue, May 22, 2012
Epocrates Announces First Quarter 2012 Results

GlobeNewswire (May 1, 2012)
Physicians Share Extraordinary Patient Safety Moments With Epocrates

GlobeNewswire (Apr 20, 2012)
Epocrates Announces First Quarter Earnings Release Date and Conference Call

GlobeNewswire (Apr 17, 2012)
Epocrates Names Andrew Hurd as President and CEO

GlobeNewswire (Mar 26, 2012)
Greenway Medical Technologies May Stand Out In a Busy Week For IPOs
Renaissance Capital IPO Research • Wed, Feb 1, 2012 • 1 Comment

To learn more about Seeking Alpha Pro, click here.

Post-Hype Sleeper: Checking Out Epocrates' Oath To Customers, Investors
Daniel Shvartsman • Tue, Jul 31, 2012 • 1 Comment
Epocrates Already Worth Shorting
StreetAuthority • Fri, Feb 25, 2011 • 17 Comments
Epocrates Prices IPO Above Range
SA Editor Mohit Manghnani • Fri, Feb 4, 2011

4 Companies Poised To Control The New Mobile App Economy
AppHead • Thu, May 24, 2012 • 11 Comments
WebMD Health: Attractive Takeover Target With Strong Competitive Advantage
NYU Value Investor • Tue, May 22, 2012
Greenway Medical Technologies May Stand Out In a Busy Week For IPOs
Renaissance Capital IPO Research • Wed, Feb 1, 2012 • 1 Comment
18 Small Cap Healthcare Stocks For A January Bounce
Alan Brochstein • Tue, Dec 27, 2011 • 5 Comments
Top 13 Undervalued Growth Stocks For 2012
Kapitall • Sat, Dec 24, 2011
7 IPOs With Poor Stock Performance: Will Groupon Follow?
David Zanoni • Wed, Nov 23, 2011
After Shaky August, IPO Market Attempts To Right Itself
IPO Candy • Fri, Sep 23, 2011 • 2 Comments
Fools Rush In...To IPOs
Vuru • Thu, Sep 15, 2011
Biotech IPO Class of 2011 Takes Drubbing
The Burrill Report • Sun, Aug 14, 2011
A Simplified ASCO 2011 List for Biotech Investor Research
Chemistfrog • Mon, May 9, 2011 • 2 Comments
The 50 Most Innovative Companies in the World
David Hunkar • Thu, Mar 3, 2011 • 14 Comments
U.S. IPOs on Top Again
Renaissance Capital IPO Research • Wed, Feb 23, 2011 • 1 Comment
Mixed Results for the U.S. IPO Market
Renaissance Capital IPO Research • Sun, Feb 6, 2011 • 5 Comments
Epocrates' Strong Market Reception: Five Life Sciences Leave the Gate Last Week
The Burrill Report • Sun, Feb 6, 2011
Epocrates IPO Analysis: Long-Term Success Depends on Electronic Records Initiative
Bill Simpson • Thu, Feb 3, 2011 • 4 Comments
12 IPOs Set to Debut This Week
Renaissance Capital IPO Research • Mon, Jan 31, 2011 • 4 Comments
Three Medical IPOs Ahead This Week: BioHorizons, Epocrates, Tornier B.V.
IPOdesktop • Sun, Jan 30, 2011 • 1 Comment

There are no Transcripts on EPOC.

Epocrates Helped Physicians Avoid 27 Million Drug Errors in 2012

GlobeNewswire (Jan 23, 2013)
Movers & Shakers: Monday’s biggest gaining and declining stocks

at MarketWatch.com (Jan 7, 2013)
Epocrates to Present at the 31st Annual J.P. Morgan Healthcare Conference

GlobeNewswire (Dec 17, 2012)
Photo Release -- Epocrates Launches Application for iPad and iPad mini

GlobeNewswire (Dec 6, 2012)
Epocrates CEO to Present at Two Healthcare Investor Conferences

GlobeNewswire (Nov 1, 2012)
Epocrates Announces Third Quarter 2012 Results

GlobeNewswire (Oct 30, 2012)
Epocrates Market Research Panel Aces Industry Report Card

GlobeNewswire (Oct 26, 2012)
Epocrates Updates Third Quarter Earnings Conference Call Time

GlobeNewswire (Oct 11, 2012)
Epocrates Announces Third Quarter Earnings Release Date and Conference Call

GlobeNewswire (Oct 9, 2012)
Stocks to Watch: GRPN, FB, GOOG & More

at CNBC.com (Sep 24, 2012)
Epocrates Invests in Future Physicians

GlobeNewswire (Aug 17, 2012)
Epocrates Announces Second Quarter 2012 Results

GlobeNewswire (Aug 7, 2012)
Epocrates Announces Second Quarter Earnings Release Date and Conference Call

GlobeNewswire (Jul 10, 2012)
Epocrates Reigns as Physicians' Top Mobile App According to New Manhattan Research Study

GlobeNewswire (May 22, 2012)
Epocrates Announces First Quarter 2012 Results

GlobeNewswire (May 1, 2012)
Physicians Share Extraordinary Patient Safety Moments With Epocrates

GlobeNewswire (Apr 20, 2012)
Epocrates Announces First Quarter Earnings Release Date and Conference Call

GlobeNewswire (Apr 17, 2012)
Epocrates Names Andrew Hurd as President and CEO

GlobeNewswire (Mar 26, 2012)
Epocrates and M3 Partner to Create the World's Largest Physician Research Panel

GlobeNewswire (Jan 3, 2012)
Epocrates to Present at 30th Annual J.P. Morgan Healthcare Conference

GlobeNewswire (Dec 28, 2011)

EPOC vs. ETF Alternatives

Company Description

Currently, there's no company description for EPOC.

Sector: Healthcare

Industry: Medical Appliances & Equipment

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Monday, January 7, 12:45 PM Midday top 10 gainers: PPHM +67%. MDCI +28%. DLGC +24%. EPOC +22%. BIOL +21%. RFIL +21%. BITA +16%. PRGN +15%. CHRM +15%. CBMX +15%.
Midday top 10 Losers: HILL -20%. ESI -17%. STP -13%. SWSH -11%. PGRX -11%. PSEM -11%. IHT -11%. CDXS -10%. ACHN -10%. NED -9%. Comment! [On the Move]
Monday, January 7, 9:24 AM Athenahealth (ATHN) agrees to acquire clinical information provider Epocrates (EPOC) for ~$293M in cash. ATHN says the acquisition should help provide better information access for health organizations, advance mobile workflows and accelerate awareness and growth across the physician market. EPOC +22.5%, ATHN -0.4% premarket. Comment! [Healthcare, M&A, On the Move]
Monday, January 7, 9:10 AM Premarket gainers: PPHM +27%. CBMX +25%. EPOC +22%. NSM +18%. ES +11%. VVUS +10%. WAC +9%. KERX +6%. SCTY +6%. NCT +6%.
Losers: ILMN -9%. SQNM -6%. 2 Comments [On the Move]
Friday, March 2, 2012, 3:10 PM Epocrates (EPOC -11.2%) shares slide after the provider of medical information systems for physicians says it will abandon a planned move into electronic health records, and issues cautionary guidance for 2012. Eric Savitz sees EPOC's troubles as a cautionary tale for investors in Yelp and other hot IPOs: "Don’t confuse first day euphoria for an investment strategy." Comment! [Tech, Healthcare, On the Move]
Wednesday, August 10, 2011, 11:51 AM Drug reference tool provider Epocrates (EPOC) falls 39% after reporting Q2 revenue of $27.9M (+10% Y/Y) and EPS of $0.13 (boosted by a one-time gain), compared with a consensus of $29.6M and $0.07. 2011 revenue guidance of $115M-$120M and EPS guidance of $0.01-$0.10 is below a consensus of $124.4M and $0.40. (PR) Comment! [Healthcare, Tech, Earnings, On the Move]

Asif Suria
New Post: Merger Arbitrage Mondays http://bit.ly/13u0j82 $ES $EPOC
Jan 14, 11:09 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Asif Suria
AthenaHealth Agrees To Buy Epocrates In $293 Million Deal $EPOC $ATHN http://bit.ly/VxblDX
Jan 7, 12:04 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

AppHead
The mobile app stock sector: MOBI, GLUU, EPOC, MIMV, VELT, AUGT, ALIF, TBOW
3/9/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

EPOC Epocrates, Inc.

EPOC

Epocrates, Inc.